+170.5%
MRNA vs STLA
-79.0%
+249.5%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | STLA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.9% | -1.9% | -2.0% | -2.9% |
| 7D | -17.6% | -14.6% | -3.0% | -9.8% |
| 30D | -5.1% | -16.7% | +11.6% | +4.7% |
| 3M | +220.8% | -28.9% | +249.7% | +294.1% |
| 6M | +321.7% | -51.4% | +373.1% | +489.1% |
| YTD | +601.3% | -66.6% | +667.8% | +1,004.3% |
| 1Y | +735.2% | -63.5% | +798.7% | +1,161.7% |
| 3Y | +170.5% | -79.1% | +249.6% | +361.1% |
| All | +170.5% | -79.0% | +249.5% | +361.1% |
Cumulative growth
Daily Returns
Daily percentage return beside STLA.
Daily Out/Under-Performance
Portfolio return minus STLA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STLA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded STLA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling